From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 526,999 shares, representing 3.08% for $7.52 million under the buyback announced on March 14, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.12 USD | +15.00% | +8.58% | -29.28% |
Apr. 16 | Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M | MT |
Apr. 16 | Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 EPS $0.26 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.28% | 184M | |
+18.66% | 414B | |
+15.27% | 242B | |
+20.63% | 104B | |
+17.19% | 83.87B | |
+54.11% | 57.64B | |
+33.59% | 53.37B | |
+6.02% | 37.83B | |
+15.88% | 34.11B | |
-8.32% | 23.18B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- Tranche Update on OptimizeRx Corporation's Equity Buyback Plan announced on March 14, 2023.